JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status

  • Authors:
    • Simone Aparecida De Bessa
    • Sibeli Salaorni
    • Diogo F.C. Patrão
    • Mário Mourão Neto
    • Maria Mitzi Brentani
    • Maria Aparecida Nagai
  • View Affiliations

  • Published online on: February 1, 2006     https://doi.org/10.3892/ijmm.17.2.363
  • Pages: 363-367
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The members of the DnaJ/Hsp40 proteins are highly conserved through evolution, expressed in several tissues and act as co-chaperone regulating protein folding, transport, translational initiation and gene expression. Recently, using cDNA microarray we identified differences in the expression of the JDP1 (DNAJC12) gene, a member of the DnaJ/Hsp40 family, between ER-positive and ER-negative breast tumours. In this study, using quantitative real-time PCR (qPCR) we evaluated the expression pattern of the JDP1 gene in a series of 72 primary breast tumours and investigated the effects of 17β-estradiol on the expression of the JDP1 in MCF-7 breast cancer cells. Three patterns of JDP1 mRNA expression were identified in the primary breast tumours analysed: normal expression was found in 14% of the cases, under-expression in 50%, and over-expression in 36% of the cases. High levels of JDP1 mRNA expression were significantly associated with estrogen receptor-positive status (p=0.02). No relationship was found between JDP1 mRNA expression and any other clinicopathological characteristics of the patients. Sequence analysis of the promoter region of the JDP1 gene revealed the presence of potential estrogen response elements (EREs), suggesting it to be under the control of estrogen action. We also assessed the effects of 17β-estradiol (10 nM) on JDP1 mRNA expression in MCF-7 breast cancer cells. The JDP1 transcripts were found to be up-regulated in a time-dependent fashion in MCF-7 cells exposed to 17β-estradiol treatment. Here we show for the first time that JDP1 is a estrogen target gene and that its expression might be used as a marker of the ER transactivation activity and may have a predictive value for response to hormonal therapy.

Related Articles

Journal Cover

February 2006
Volume 17 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
De Bessa SA, Salaorni S, Patrão DF, Neto MM, Brentani MM and Nagai MA: JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status. Int J Mol Med 17: 363-367, 2006
APA
De Bessa, S.A., Salaorni, S., Patrão, D.F., Neto, M.M., Brentani, M.M., & Nagai, M.A. (2006). JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status. International Journal of Molecular Medicine, 17, 363-367. https://doi.org/10.3892/ijmm.17.2.363
MLA
De Bessa, S. A., Salaorni, S., Patrão, D. F., Neto, M. M., Brentani, M. M., Nagai, M. A."JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status". International Journal of Molecular Medicine 17.2 (2006): 363-367.
Chicago
De Bessa, S. A., Salaorni, S., Patrão, D. F., Neto, M. M., Brentani, M. M., Nagai, M. A."JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status". International Journal of Molecular Medicine 17, no. 2 (2006): 363-367. https://doi.org/10.3892/ijmm.17.2.363